Our Terms of Service and Privacy Policy have changed.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
| 13.33 BATS BZX Real-Time Price As of 12:46pm ET |  +0.31 / +2.38%Today’s Change | 8.67 Today|||52-Week Range 14.55 | +24.58% Year-to-Date |
| Previous close | 13.02 |
| Today’s open | 13.04 |
| Day’s range | 13.03 - 13.34 |
| Volume | 30,770 |
| Average volume (3 months) | 1,147,794 |
| Market cap | $1.4B |
| Dividend yield | -- |
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +111.32% |
| Earnings growth (next 5 years) | +3.00% |
| Revenue growth (last year) | +117.48% |
| P/E ratio | 20.7 |
| Price/Sales | 8.95 |
| Price/Book | -- |
| Today’s change | Today’s % change | |
|---|---|---|
| EBSEmergent BioSolution... | +0.67 | +1.92% |
| ARRYArray Biopharma Inc | +0.04 | +0.47% |
| ---- | ||
| CORTCorcept Therapeutics... | 0.00 | 0.00% |
| Next reporting date | August 2, 2017 |
| EPS forecast (this quarter) | $0.28 |
| Annual revenue (last year) | $147.4M |
| Annual profit (last year) | $59.5M |
| Net profit margin | 40.39% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
President, Chief Executive Officer & Director Michael W. Aguiar |
Chief Financial Officer & Senior Vice President Eric d'Esparbes |
Corporate headquarters Brisbane, California |
